# Pulsed-field Ablation in Patients With Persistent Atrial Fibrillation

Study · id `cardio:ct-nct05922917` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05922917](<https://clinicaltrials.gov/study/NCT05922917>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT05922917

Browse, organ or system: Heart  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 518 participants.

## Technical summary

Registry record NCT05922917. Randomized; double masking; primary purpose treatment. Start 2023-06-20 (actual); primary completion 2026-07-31 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 518 participants (enrolled count; ClinicalTrials.gov record NCT05922917, source copy `cardio:ctgov-nct05922917-2026-10-30`, retrieved 2026-10-31)
- Started: 2023-06-20 (actual) (ClinicalTrials.gov record NCT05922917, source copy `cardio:ctgov-nct05922917-2026-10-30`, retrieved 2026-10-31)
- Primary completion: 2026-07-31 (actual) (ClinicalTrials.gov record NCT05922917, source copy `cardio:ctgov-nct05922917-2026-10-30`, retrieved 2026-10-31)
- Completion: 2026-10-22 (actual) (ClinicalTrials.gov record NCT05922917, source copy `cardio:ctgov-nct05922917-2026-10-30`, retrieved 2026-10-31)
- Countries: Czechia (ClinicalTrials.gov record NCT05922917, source copy `cardio:ctgov-nct05922917-2026-10-30`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05922917-2026-10-30`, retrieved 2026-10-31)

## The registry's words

- Brief title: Pulsed-field Ablation in Patients With Persistent Atrial Fibrillation
- Acronym: PIVCO
- Condition: Persistent Atrial Fibrillation
- Condition: Pulsed-field Ablation
- Intervention (Device): pulsed-field ablation
- Lead sponsor: České Budějovice Hospital
- Lead sponsor class: OTHER
- Collaborator: University Hospital Olomouc
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry lists this organization as a collaborator: University Hospital Olomouc (`cardio:org-university-hospital-olomouc`)

## Provenance

Content hash: 478540cb55a49d4d73b8792a6356da9fdc5f401cf0b5f3799edd97c3f6bc3dd0
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
